Julian Vance

Fasting insulin has become a favourite marker in metabolic-health circles because it seems to promise an earlier warning than glucose. The idea is plausible: insulin can rise for years whilst fasting glucose still looks normal. The harder question is whether one fasting insulin result tells an individual what to do next. Usually, it does less … Read more

Eating earlier may modestly help glucose control, but the evidence supports timing as a small metabolic lever, not a stand-alone treatment for everyone.

Late meals can worsen glucose handling for some people, but timing is a signal to adjust, not a moral rule. Here is what the evidence actually shows.

Morning glucose can rise before breakfast because liver output and insulin timing fall out of step. Here is what the dawn phenomenon does and does not prove.

Changing meal order can reduce post-meal glucose excursions, but the evidence supports a modest habit, not a cure for metabolic disease on its own.

Fasting-mimicking diets may improve some metabolic markers in small trials, but they are not proven longevity treatment and need medical caution.

Intermittent fasting does not automatically cost muscle mass, but protein intake, training, and deficit size matter more than the eating window alone.

Home blood pressure monitoring can clarify risk and treatment response, but cuff fit, technique, averages, and clinical context decide what it means.

Metabolic syndrome can flag clustered cardiometabolic risk, but it needs context, repeatable habits, and medical caution rather than a one-size-fits-all fix.

Prediabetes is a useful warning signal, but not a diagnosis with a countdown. Here is what the evidence says about risk, testing, and limits.